Inhibition mechanism and the effects of structure on activity of male reproduction-related peptidase inhibitor Kazal-type (MRPINK) of Macrobrachium rosenbergii.
In our previous reports, a Kazal family serine protease inhibitor, male reproduction-related peptidase inhibitor Kazal-type (MRPINK) has been identified from the prawn, Macrobrachium rosenbergii, and discovered having an inhibitory effect on the sperm gelatinolytic activity. MRPINK was predicated to inhibit chymotrypsin since it contains leucine and proline at P(1) positions of the two domains, respectively. In this report, recombinant MRPINK was as expected found to specifically inhibit chymotrypsin, but no inhibition was detected against trypsin or thrombin. By the analysis of kinetic tests, the inhibition mechanism of MRPINK was determined to be typical competitive model with K (i) of 354 nM. To elucidate the effects of structure on activity of MRPINK, the mutants (domain-1 only, domain-2 only, MRPINK(P88I), MRPINK(L37K), MRPINK(L37A), and MRPINK(L37G)) were prepared and their inhibitory activities assayed. The results showed that domain-2 was the key contributor to the inhibition of chymotrypsin (K (i) of 416 nM) and P(1) Pro was crucial for the activity. Nevertheless, whether the P(1) amino acid residue was Leu, or even if it was replaced by Lys, Ala, or Gly, domain-1 was ineffective to the activity.
Li
Ye
Y
Institute of Cell Biology and Genetics, College of Life Sciences, Zijingang Campus, Zhejiang University, Hangzhou, Zhejiang, 310058, People's Republic of China.
Qian
Ye-Qing
YQ
Ma
Wen-Ming
WM
Yang
Wei-Jun
WJ
D000595:Amino Acid Sequence; D000818:Animals; D002918:Chymotrypsin / Q000037:antagonists & inhibitors; D008297:Male; D008969:Molecular Sequence Data; D009154:Mutation; D033541:Palaemonidae / Q000737:chemistry / Q000378:metabolism*; D017434:Protein Structure, Tertiary; D011994:Recombinant Proteins / Q000378:metabolism; D012098:Reproduction / Q000502:physiology; D015842:Serine Proteinase Inhibitors / Q000737:chemistry* / Q000235:genetics / Q000494:pharmacology*; D013997:Time Factors
D011994:Recombinant Proteins; D015842:Serine Proteinase Inhibitors; D002918:Chymotrypsin
J Biol Chem. 1997 Aug 8;272(32):19931-7
9242660
Biol Reprod. 1973 Oct;9(3):219-25
4201110
Biochim Biophys Acta. 2005 Apr 15;1748(1):57-65
15752693
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1410-5
11171964
J Biol Chem. 1999 Jul 30;274(31):21499-502
10419450
Mar Biotechnol (NY). 2007 Jan-Feb;9(1):45-55
16967183
C R Biol. 2007 Jun-Jul;330(6-7):491-7
17631443
Biochem J. 2004 Mar 15;378(Pt 3):705-16
14705960
Eur J Biochem. 1999 Feb;259(3):872-6
10092876
Dev Comp Immunol. 2005;29(5):385-91
15707660
J Mol Biol. 2002 Apr 26;318(2):533-46
12051857
Protein Expr Purif. 2004 May;35(1):93-101
15039071
Eur J Biochem. 1994 Jul 15;223(2):389-94
8055907
Dev Comp Immunol. 2006;30(11):998-1008
16519941
Anal Biochem. 1976 May 7;72:248-54
942051
Cell Mol Life Sci. 2003 Nov;60(11):2427-44
14625687
Mar Biotechnol (NY). 2005 Jan-Feb;7(1):46-52
15756478
BMC Biochem. 2005 Aug 23;6:15
16117831
Cell Mol Life Sci. 1997 Jan;53(1):13-23
9117993
J Clin Invest. 2000 Dec;106(12):1531-9
11120760
Fish Shellfish Immunol. 2006 Mar;20(3):320-31
16005644
Biochemistry. 1987 Jan 13;26(1):193-201
3548816
Dev Comp Immunol. 1999 Jun-Jul;23(4-5):291-301
10426423
Mol Biol Cell. 2007 Sep;18(9):3607-19
17596512
Eur J Biochem. 1998 Apr 1;253(1):212-20
9578479
J Biol Chem. 1993 Aug 5;268(22):16216-22
8344906
Arch Biochem Biophys. 2004 May 1;425(1):87-94
15081897
Biochim Biophys Acta. 1998 Sep 8;1387(1-2):415-21
9748658
Comp Biochem Physiol B Biochem Mol Biol. 2007 Feb;146(2):234-40
17161640
Protein Sci. 1995 Oct;4(10):1985-97
8535235
Mol Reprod Dev. 2008 Aug;75(8):1327-37
18324674
Comp Biochem Physiol B Biochem Mol Biol. 2002 May;132(1):247-55
11997226
J Biol Chem. 2002 Nov 22;277(47):45259-66
12228242
Biochemistry. 1997 Feb 18;36(7):1598-607
9048543
Annu Rev Biochem. 1980;49:593-626
6996568
Proteins. 2006 May 15;63(3):697-708
16463276
Eur J Biochem. 1992 Mar 1;204(2):433-51
1541261